Literature DB >> 9851931

Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors.

J T Nguyen1, C W Turck, F E Cohen, R N Zuckermann, W A Lim.   

Abstract

Src homology 3 (SH3) and WW protein interaction domains bind specific proline-rich sequences. However, instead of recognizing critical prolines on the basis of side chain shape or rigidity, these domains broadly accepted amide N-substituted residues. Proline is apparently specifically selected in vivo, despite low complementarity, because it is the only endogenous N-substituted amino acid. This discriminatory mechanism explains how these domains achieve specific but low-affinity recognition, a property that is necessary for transient signaling interactions. The mechanism can be exploited: screening a series of ligands in which key prolines were replaced by nonnatural N-substituted residues yielded a ligand that selectively bound the Grb2 SH3 domain with 100 times greater affinity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9851931     DOI: 10.1126/science.282.5396.2088

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  67 in total

1.  Evolution of binding affinity in a WW domain probed by phage display.

Authors:  P A Dalby; R H Hoess; W F DeGrado
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

2.  A single WW domain is the predominant mediator of the interaction between the human ubiquitin-protein ligase Nedd4 and the human epithelial sodium channel.

Authors:  J Shaun Lott; Sarah J Coddington-Lawson; Paul H Teesdale-Spittle; Fiona J McDonald
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

3.  Topography for independent binding of alpha-helical and PPII-helical ligands to a peroxisomal SH3 domain.

Authors:  Alice Douangamath; Fabian V Filipp; André T J Klein; Phil Barnett; Peijian Zou; Tineke Voorn-Brouwer; M Cristina Vega; Olga M Mayans; Michael Sattler; Ben Distel; Matthias Wilmanns
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

4.  Recognition of tandem PxxP motifs as a unique Src homology 3-binding mode triggers pathogen-driven actin assembly.

Authors:  Olli Aitio; Maarit Hellman; Arunas Kazlauskas; Didier F Vingadassalom; John M Leong; Kalle Saksela; Perttu Permi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

5.  Directed discovery of bivalent peptide ligands to an SH3 domain.

Authors:  Monique R Ferguson; Xiuzhen Fan; Munia Mukherjee; Jinquan Luo; Raza Khan; Josephine C Ferreon; Vincent J Hilser; Robert E Shope; Robert O Fox
Journal:  Protein Sci       Date:  2004-03       Impact factor: 6.725

6.  Fragmentation Patterns and Mechanisms of Singly and Doubly Protonated Peptoids Studied by Collision Induced Dissociation.

Authors:  Jianhua Ren; Yuan Tian; Ekram Hossain; Michael D Connolly
Journal:  J Am Soc Mass Spectrom       Date:  2016-02-01       Impact factor: 3.109

7.  Site-specifically arraying small molecules or proteins on DNA using an expanded genetic alphabet.

Authors:  Zhengtao Li; Thomas Lavergne; Denis A Malyshev; Jörg Zimmermann; Ramkrishna Adhikary; Kirandeep Dhami; Phillip Ordoukhanian; Zhelin Sun; Jie Xiang; Floyd E Romesberg
Journal:  Chemistry       Date:  2013-09-11       Impact factor: 5.236

8.  The C2 domain protein Cts1 functions in the calcineurin signaling circuit during high-temperature stress responses in Cryptococcus neoformans.

Authors:  Eanas F Aboobakar; Xuying Wang; Joseph Heitman; Lukasz Kozubowski
Journal:  Eukaryot Cell       Date:  2011-10-14

Review 9.  Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction.

Authors:  Shawn S-C Li
Journal:  Biochem J       Date:  2005-09-15       Impact factor: 3.857

10.  Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p.

Authors:  Keiichiro Kami; Ryu Takeya; Hideki Sumimoto; Daisuke Kohda
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.